JOHN ERNST: Open Payments
NPI 1134470388 · KILLEEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$901 in 35 payments from 9 companies in 2025. Trend: 2023 $465 · 2024 $711 · 2025 $901
Food & beverage: $803Education: $98
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $305 |
| GENZYME CORPORATION | 5 | $153 |
| SANOFI-AVENTIS U.S. LLC | 1 | $98 |
| Verona Pharma, Inc. | 4 | $92 |
| Ionis Pharmaceuticals, Inc. | 3 | $72 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| CSL Behring | 2 | $47 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
Products named: DUPIXENT, FASENRA, Ohtuvayre, BREZTRI, TEZSPIRE, DAWNZERA, TRELEGY ELLIPTA, Hizentra.
Industry payments across TX — which companies pay providers there.
